1 / 5

Overall (I-squared = 2.0%, p = 0.426)

Events,. Events,. %. Authors. OR (95% CI). RR (95% CI). Treatment. Cases. Control. Weight. Aggerholm et al., 2008. 1.05 (0.17, 6.65). 1.05 (0.17, 6.65). 1/8. 1/8. 103/868. 1.37. Braga et al., 2012. 0.50 (0.09, 2.92). 0.50 (0.09, 2.92). 1/5. 1/5. 50/125. 1.49.

harriet-mcdowell
Download Presentation

Overall (I-squared = 2.0%, p = 0.426)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Events, Events, % Authors OR (95% CI) RR (95% CI) Treatment Cases Control Weight Aggerholm et al., 2008 1.05 (0.17, 6.65) 1.05 (0.17, 6.65) 1/8 1/8 103/868 1.37 Braga et al., 2012 0.50 (0.09, 2.92) 0.50 (0.09, 2.92) 1/5 1/5 50/125 1.49 Duits et al., 2009 0.81 (0.13, 4.85) 0.81 (0.13, 4.85) 1/6 1/6 137/662 1.44 Eskandar et al., 2012 1.49 (0.70, 3.18) 1.49 (0.70, 3.18) 12/54 12/54 10/67 7.93 Hammiche et al., 2012 0.57 (0.10, 3.31) 0.57 (0.10, 3.31) 1/5 1/5 54/153 1.49 Jensen et al., 2004 0.94 (0.69, 1.30) 0.94 (0.69, 1.30) 23/55 23/55 533/1204 40.61 Keltz et al., 2010 & Relwani et al., 2011 1.70 (0.71, 4.06) 1.70 (0.71, 4.06) 1/1 1/1 18/41 6.07 Koloszar et al., 2005 & Fejes et al., 2005 & Fejes et al., 2006 1.64 (1.01, 2.66) 1.64 (1.01, 2.66) 13/30 13/30 42/159 18.81 Li et al., 2009 0.82 (0.37, 1.82) 0.82 (0.37, 1.82) 6/92 6/92 79/991 7.12 Ramlau-Hansen et al., 2009 1.40 (0.52, 3.76) 1.40 (0.52, 3.76) 3/10 3/10 40/187 4.75 Shayeb et al., 2011 0.35 (0.05, 2.34) 0.35 (0.05, 2.34) 1/17 1/17 136/802 1.28 Vujkovic et al., 2009 & Hammiche et al., 2011 0.34 (0.03, 4.30) 0.34 (0.03, 4.30) 0/2 0/2 50/102 0.72 Lévy et al., unpublished 1.96 (0.87, 4.42) 1.96 (0.87, 4.42) 2/3 2/3 111/326 6.91 Overall (I-squared = 2.0%, p = 0.426) 1.15 (0.93, 1.43) 1.15 (0.93, 1.43) 65/288 65/288 1363/5687 100.00 .0269 1 1 37.2 Lower prevalence in underweight Higher prevalence in underweight

  2. Events, Events, % Authors RR (95% CI) OR (95% CI) Cases Treatment Control Weight Aggerholm et al., 2008 1.18 (0.91, 1.53) 1.18 (0.91, 1.53) 92/657 92/657 103/868 6.67 Braga et al., 2012 0.65 (0.44, 0.96) 0.65 (0.44, 0.96) 26/100 26/100 50/125 3.99 Chavarro et al., 2009 1.20 (0.61, 2.36) 1.20 (0.61, 2.36) 25/233 25/233 11/123 1.67 Duits et al., 2009 1.09 (0.88, 1.34) 1.09 (0.88, 1.34) 132/587 132/587 137/662 8.19 Eskandar et al., 2012 1.06 (0.52, 2.15) 1.06 (0.52, 2.15) 19/120 19/120 10/67 1.55 Eskenazi et al., 2003 2.39 (0.89, 6.43) 2.39 (0.89, 6.43) 10/41 10/41 5/49 0.83 Hammiche et al., 2012 1.24 (0.96, 1.61) 1.24 (0.96, 1.61) 97/221 97/221 54/153 6.69 Jensen et al., 2004 1.16 (1.01, 1.33) 1.16 (1.01, 1.33) 123/240 123/240 533/1204 10.81 Keltz et al., 2010 & Relwani et al., 2011 0.99 (0.65, 1.51) 0.99 (0.65, 1.51) 38/87 38/87 18/41 3.64 Koloszar et al., 2005 & Fejes et al., 2005 & Fejes et al., 2006 1.11 (0.78, 1.59) 1.11 (0.78, 1.59) 45/153 45/153 42/159 4.58 La Vignera et al., 2012 3.00 (1.65, 5.46) 3.00 (1.65, 5.46) 30/50 30/50 10/50 2.06 Li et al., 2009 1.36 (0.90, 2.08) 1.36 (0.90, 2.08) 26/239 26/239 79/991 3.64 Lotti et al., 2011 1.06 (0.85, 1.33) 1.06 (0.85, 1.33) 45/71 45/71 78/131 7.72 Magnusdottir et al., 2005 0.81 (0.30, 2.22) 0.81 (0.30, 2.22) 6/32 6/32 6/26 0.80 Martini et al., 2010 1.10 (0.95, 1.28) 1.10 (0.95, 1.28) 218/392 218/392 124/246 10.30 Ramlau-Hansen et al., 2009 0.91 (0.48, 1.75) 0.91 (0.48, 1.75) 9/46 9/46 40/187 1.80 Shayeb et al., 2011 1.10 (0.89, 1.35) 1.10 (0.89, 1.35) 164/883 164/883 136/802 8.37 Tunc et al., 2011 2.46 (0.79, 7.66) 2.46 (0.79, 7.66) 13/37 13/37 3/21 0.64 Vujkovic et al., 2009 & Hammiche et al., 2011 0.66 (0.47, 0.93) 0.66 (0.47, 0.93) 33/102 33/102 50/102 4.83 Zorn et al., 2007 & Zorn et al., 2012 1.14 (0.71, 1.84) 1.14 (0.71, 1.84) 25/79 25/79 23/83 3.01 Lévy et al., unpublished 1.15 (0.93, 1.42) 1.15 (0.93, 1.42) 109/279 109/279 111/326 8.22 Overall (I-squared = 41.6%, p = 0.024) 1.11 (1.01, 1.21) 1.11 (1.01, 1.21) 1285/4649 1285/4649 1623/6416 100.00 .131 1 1 7.66 Lower prevalence in overweight Higher prevalence in overweight

  3. Events, Events, % Authors OR (95% CI) RR (95% CI) Cases Treatment Control Weight Aggerholm et al., 2008 0.62 (0.33, 1.16) 0.62 (0.33, 1.16) 10/135 10/135 103/868 4.47 Braga et al., 2012 0.50 (0.14, 1.76) 0.50 (0.14, 1.76) 2/10 2/10 50/125 1.81 Chavarro et al., 2009 1.26 (0.59, 2.71) 1.26 (0.59, 2.71) 13/115 13/115 11/123 3.61 Duits et al., 2009 2.24 (1.77, 2.83) 2.24 (1.77, 2.83) 63/136 63/136 137/662 7.60 Eskandar et al., 2012 1.06 (0.53, 2.12) 1.06 (0.53, 2.12) 21/133 21/133 10/67 4.01 Eskenazi et al., 2003 1.40 (0.19, 10.30) 1.40 (0.19, 10.30) 1/7 1/7 5/49 0.82 Hammiche et al., 2012 1.29 (0.92, 1.81) 1.29 (0.92, 1.81) 31/68 31/68 54/153 6.77 Jensen et al., 2004 1.15 (0.88, 1.49) 1.15 (0.88, 1.49) 29/57 29/57 533/1204 7.38 Keltz et al., 2010 & Relwani et al., 2011 1.05 (0.67, 1.65) 1.05 (0.67, 1.65) 25/54 25/54 18/41 5.80 Koloszar et al., 2005 & Fejes et al., 2005 & Fejes et al., 2006 1.67 (1.19, 2.35) 1.67 (1.19, 2.35) 46/104 46/104 42/159 6.76 La Vignera et al., 2012 2.50 (1.32, 4.72) 2.50 (1.32, 4.72) 20/40 20/40 10/50 4.39 Li et al., 2009 1.57 (0.42, 5.83) 1.57 (0.42, 5.83) 2/16 2/16 79/991 1.69 Lotti et al., 2011 0.50 (0.25, 1.00) 0.50 (0.25, 1.00) 6/20 6/20 78/131 4.07 Magnusdottir et al., 2005 3.94 (1.91, 8.14) 3.94 (1.91, 8.14) 10/11 10/11 6/26 3.81 Martini et al., 2010 1.11 (0.92, 1.35) 1.11 (0.92, 1.35) 82/146 82/146 124/246 7.91 Ramlau-Hansen et al., 2009 0.88 (0.30, 2.52) 0.88 (0.30, 2.52) 3/16 3/16 40/187 2.35 Shayeb et al., 2011 1.22 (0.92, 1.63) 1.22 (0.92, 1.63) 51/246 51/246 136/802 7.17 Tunc et al., 2011 2.13 (0.63, 7.19) 2.13 (0.63, 7.19) 7/23 7/23 3/21 1.90 Vujkovic et al., 2009 & Hammiche et al., 2011 0.97 (0.58, 1.62) 0.97 (0.58, 1.62) 9/19 9/19 50/102 5.28 Zorn et al., 2007 & Zorn et al., 2012 2.14 (1.34, 3.41) 2.14 (1.34, 3.41) 16/27 16/27 23/83 5.65 Lévy et al., unpublished 0.88 (0.62, 1.23) 0.88 (0.62, 1.23) 29/97 29/97 111/326 6.74 Overall (I-squared = 70.6%, p = 0.000) 1.28 (1.06, 1.55) 1.28 (1.06, 1.55) 476/1480 476/1480 1623/6416 100.00 .0971 1 1 10.3 Lower prevalence in obese Higher prevalence in obese

  4. Events, Events, % OR (95% CI) RR (95% CI) Treatment Cases Control Weight Authors Aggerholm et al., 2008 2.10 (0.19, 23.31) 2.10 (0.19, 23.31) 0/1 0/1 103/868 1.03 Braga et al., 2012 1.75 (1.11, 2.77) 1.75 (1.11, 2.77) 7/10 7/10 50/125 12.88 Chavarro et al., 2009 2.80 (0.90, 8.66) 2.80 (0.90, 8.66) 3/12 3/12 11/123 4.02 Duits et al., 2009 0.48 (0.07, 3.12) 0.48 (0.07, 3.12) 1/10 1/10 137/662 1.66 Eskandar et al., 2012 4.79 (2.67, 8.57) 4.79 (2.67, 8.57) 90/126 90/126 10/67 10.18 Hammiche et al., 2012 1.42 (0.35, 5.76) 1.42 (0.35, 5.76) 1/2 1/2 54/153 2.79 Jensen et al., 2004 1.13 (0.28, 4.52) 1.13 (0.28, 4.52) 1/2 1/2 533/1204 2.84 Keltz et al., 2010 & Relwani et al., 2011 1.14 (0.27, 4.75) 1.14 (0.27, 4.75) 1/2 1/2 18/41 2.70 Koloszar et al., 2005 & Fejes et al., 2005 & Fejes et al., 2006 2.38 (1.62, 3.52) 2.38 (1.62, 3.52) 17/27 17/27 42/159 14.69 La Vignera et al., 2012 3.00 (1.42, 6.35) 3.00 (1.42, 6.35) 6/10 6/10 10/50 7.45 Magnusdottir et al., 2005 0.52 (0.04, 7.56) 0.52 (0.04, 7.56) 0/3 0/3 6/26 0.84 Martini et al., 2010 1.88 (1.56, 2.28) 1.88 (1.56, 2.28) 9/9 9/9 124/246 20.18 Shayeb et al., 2011 1.97 (1.00, 3.85) 1.97 (1.00, 3.85) 6/18 6/18 136/802 8.62 Lévy et al., unpublished 1.47 (0.82, 2.64) 1.47 (0.82, 2.64) 6/12 6/12 111/326 10.12 Overall (I-squared = 42.7%, p = 0.046) 2.04 (1.59, 2.62) 2.04 (1.59, 2.62) 148/244 148/244 1345/4852 100.00 .0357 1 1 28 Lower prevalence in morbid obese Higher prevalence in morbid obese

  5. Events, Events, % RR (95% CI) OR (95% CI) Cases Treatment Control Weight Authors General population Aggerholm et al., 2008 1.08 (0.84, 1.40) 1.08 (0.84, 1.40) 102/793 102/793 103/868 6.34 Eskenazi et al., 2003 2.25 (0.84, 5.98) 2.25 (0.84, 5.98) 11/48 11/48 5/49 0.95 Jensen et al., 2004 1.16 (1.02, 1.31) 1.16 (1.02, 1.31) 153/299 153/299 533/1204 9.26 La Vignera et al., 2012 2.80 (1.57, 5.01) 2.80 (1.57, 5.01) 56/100 56/100 10/50 2.32 Li et al., 2009 1.38 (0.92, 2.07) 1.38 (0.92, 2.07) 28/255 28/255 79/991 3.85 Ramlau-Hansen et al., 2009 0.90 (0.51, 1.61) 0.90 (0.51, 1.61) 12/62 12/62 40/187 2.34 Subtotal (I-squared = 58.9%, p = 0.033) 1.30 (1.03, 1.65) 1.30 (1.03, 1.65) 362/1557 362/1557 770/3349 25.07 . Infertile population Braga et al., 2012 0.73 (0.51, 1.04) 0.73 (0.51, 1.04) 35/120 35/120 50/125 4.63 Chavarro et al., 2009 1.27 (0.68, 2.40) 1.27 (0.68, 2.40) 41/360 41/360 11/123 2.02 Duits et al., 2009 1.29 (1.07, 1.56) 1.29 (1.07, 1.56) 196/733 196/733 137/662 7.79 Eskandar et al., 2012 2.30 (1.28, 4.14) 2.30 (1.28, 4.14) 130/379 130/379 10/67 2.27 Hammiche et al., 2012 1.26 (0.98, 1.61) 1.26 (0.98, 1.61) 129/291 129/291 54/153 6.47 Keltz et al., 2010 & Relwani et al., 2011 1.02 (0.69, 1.51) 1.02 (0.69, 1.51) 64/143 64/143 18/41 4.08 1.44 (1.07, 1.94) 1.44 (1.07, 1.94) 108/284 108/284 42/159 5.51 Koloszar et al., 2005 & Fejes et al., 2005 & Fejes et al., 2006 Lotti et al., 2011 0.94 (0.75, 1.19) 0.94 (0.75, 1.19) 51/91 51/91 78/131 6.90 Magnusdottir et al., 2005 1.51 (0.67, 3.37) 1.51 (0.67, 3.37) 16/46 16/46 6/26 1.34 Martini et al., 2010 1.12 (0.97, 1.29) 1.12 (0.97, 1.29) 309/547 309/547 124/246 8.89 Shayeb et al., 2011 1.14 (0.94, 1.38) 1.14 (0.94, 1.38) 221/1147 221/1147 136/802 7.73 Tunc et al., 2011 2.33 (0.77, 7.06) 2.33 (0.77, 7.06) 20/60 20/60 3/21 0.76 Vujkovic et al., 2009 & Hammiche et al., 2011 0.71 (0.52, 0.97) 0.71 (0.52, 0.97) 42/121 42/121 50/102 5.23 Zorn et al., 2007 & Zorn et al., 2012 1.40 (0.92, 2.13) 1.40 (0.92, 2.13) 41/106 41/106 23/83 3.69 Lévy et al., unpublished 1.09 (0.89, 1.33) 1.09 (0.89, 1.33) 144/388 144/388 111/326 7.61 Subtotal (I-squared = 55.8%, p = 0.004) 1.13 (1.01, 1.27) 1.13 (1.01, 1.27) 1547/4816 1547/4816 853/3067 74.93 . Overall (I-squared = 55.1%, p = 0.001) 1.17 (1.06, 1.29) 1.17 (1.06, 1.29) 1909/6373 1909/6373 1623/6416 100.00 .142 1 1 7.06 Lower prevalence in abnormal weight Higher prevalence in in abnormal weight

More Related